Your session is about to expire
← Back to Search
Other
Beta Glucan for Upper Respiratory Tract Infections
N/A
Recruiting
Led By Mark Levy, PhD
Research Sponsored by USANA Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
Study Summary
This trial tests if a supplement can help athletes avoid, lessen, and shorten upper respiratory illnesses.
Who is the study for?
This trial is for healthy individuals aged 18-30 who can attend scheduled appointments and follow study requirements. It's not for pregnant or nursing women, those with gastrointestinal issues, recent clinical study participants, pill-swallowing difficulties, tobacco users, recent cancer history (except non-melanoma skin cancer), substance abuse in the past 2 years, or on immunosuppressants.Check my eligibility
What is being tested?
The study tests if beta-glucan supplements can lower how often skiers get upper respiratory tract infections (URTIs), make them less severe or shorten their duration. Participants will either receive the supplement or a placebo without knowing which one they're taking.See study design
What are the potential side effects?
While specific side effects are not listed for beta-glucan supplements in this summary, common reactions to dietary supplements may include digestive discomfort such as bloating or gas.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Upper respiratory tract symptoms
Secondary outcome measures
Athlete psychological stress
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Dietary supplement interventionExperimental Treatment1 Intervention
Participants were treated with 2 beta-glucan containing tablets per day for a total duration of 6 weeks.
Group II: Placebo TreatmentPlacebo Group1 Intervention
a placebo tablet (microcrystalline cellulose) identical in size, shape and color to the treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Treatment
2013
Completed Phase 2
~13740
Find a Location
Who is running the clinical trial?
USANA Health SciencesLead Sponsor
10 Previous Clinical Trials
701 Total Patients Enrolled
Mark Levy, PhDPrincipal InvestigatorUSANA Health Sciences
2 Previous Clinical Trials
65 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a digestive system condition like inflammatory bowel disease or Crohn's disease that may make it hard for you to take the treatment supplements.You have difficulty swallowing pills.You currently use any form of tobacco, like cigarettes or chewing tobacco.You have had any type of cancer other than non-melanoma skin cancer in the recent past.People between 18 and 30 years old, regardless of their race or ethnic background.You are currently taking prescription medications that weaken your immune system.You have significant health issues with your kidneys, liver, heart, lungs, pancreas, or nervous system. If you need insulin or oral medications for diabetes, you cannot participate.You have had a problem with drinking too much alcohol or using drugs in the past 2 years.
Research Study Groups:
This trial has the following groups:- Group 1: Placebo Treatment
- Group 2: Dietary supplement intervention
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment currently being accepted in this research project?
"Affirmative. Clinicaltrials.gov's data supports the fact that this research trial is presently seeking volunteers, with 45 patients being required across 1 centre for enrolment since its initial posting on March 6th 2023 until June 14th of the same year."
Answered by AI
Is it possible for me to partake in this research?
"In order to be eligible, applicants must have a diagnosis of the common cold and should fall between 18-30 years old. This trial is accepting up to 45 individuals into the study."
Answered by AI
Are geriatric patients being enrolled in this research project?
"This clinical trial solicits applicants aged between 18 and 30 years of age. Additionally, there are 224 studies available for those below the age of consent and 701 for individuals above 65."
Answered by AI
How many individuals have opted to join this trial?
"Affirmative, the clinicaltrials.gov website reveals that this research effort is currently accepting applicants. This study was first published on March 6th 2023 and has been updated as recently as June 14th 2023. There are 45 participants needed for this trial held at a single location."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger